EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Management of Inflammatory Bowel Disease Using E-health Technologies: A Systematic Review and Meta-Analysis

Anish J Kuriakose Kuzhiyanjal, Gaurav B Nigam iD, George A Antoniou, Francis A Farraye, Raymond K Cross, Jimmy K Limdi iD

Journal of Crohn's and Colitis · 08.11.2023 · 17 (10) · 1596-1613

DOI: 10.1093/ecco-jcc/jjad075 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Crohn's and Colitis, online erschienen am 26.04.2023. Verfasst von Anish J Kuriakose Kuzhiyanjal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Northern Care Alliance NHS Foundation Trust, Division of Gastroenterology-Section of IBD, Manchester, UK; and. Edgehill University, Ormskirk, UK. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Telemedicine. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Technological advances have provided innovative, adaptive, and responsive models of care for inflammatory bowel diseases [IBD]. We conducted a systematic review to compare e-health interventions with standard care in management of IBD.

Methods

We searched electronic databases for randomised, controlled trials [RCT] comparing e-health interventions with standard care for patients with IBD. Effect measures were standardised mean difference [SMD], odds ratio [OR], or rate ratio [RR], calculated using the inverse variance or Mantel–Haenszel statistical method and random-effects models. Version 2 of the Cochrane tool was used to assess the risk of bias. The certainty of evidence was appraised with the GRADE framework Results Fourteen RCTs [n = 3111; 1754 e-health and 1357 controls] were identified. The difference in disease activity scores (SMD 0.09, 95% confidence interval [CI]: -0.09-0.28) and clinical remission (odds ratio [OR] 1.12, 95% CI: 0.78-1.61) between e-health interventions and standard care were not statistically significant. Higher quality of life [QoL] [SMD 0.20, 95% CI: 0.05-0.35) and IBD knowledge [SMD 0.23, 95% CI: 0.10-0.36] scores were noted in the e-health group, and self-efficacy levels [SMD -0.09, 95% CI: -0.22-0.05] were comparable. E-health patients had fewer office [RR 0.85, 95% CI: 0.78-0.93] and emergency [RR 0.70, 95% CI: 0.51- 0.95] visits, with no statistically significant difference in endoscopic procedures, total health care encounters, corticosteroid use, and IBD related hospitalisation or surgery. The trials were judged to be at high risk of bias or to have some concerns for disease remission. The certainty of evidence was moderate or low.

Conclusion

E-health technologies may have a role in value-based care in IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesTelemedicineHumans

Stichwörter der Autor:innen

Inflammatory bowel diseasee-healthtelemedicine

Autor:innen und Institutionen

  • Northern Care Alliance NHS Foundation Trust, Division of Gastroenterology-Section of IBD, Manchester, UK; and. Edgehill University, Ormskirk, UK.
  • Translational Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; and Oxford University Clinical Academic Graduate School, University of Oxford, Oxford, UK.
  • Department of Vascular and Endovascular Surgery, Manchester University NHS Foundation Trust, Manchester, UK; and Division of Cardiovascular Sciences, School of Medical Sciences, Manchester Academic Health Science Centre…
  • Mayo Clinic, Division of Gastroenterology and Hepatology, Jacksonville, FL, USA.
  • University of Maryland School of Medicine, Division of Gastroenterology & Hepatology, Baltimore, MD, USA.
  • Northern Care Alliance NHS Foundation Trust, Division of Gastroenterology-Section of IBD, Manchester, UK; and Manchester Academic Health Sciences, University of Manchester, Manchester, UK.

ORCID-Profile: Gaurav B Nigam, Jimmy K Limdi

Zitieren

APA

Kuriakose Kuzhiyanjal, A. J., Nigam, G. B., Antoniou, G. A., Farraye, F. A., Cross, R. K., & Limdi, J. K. (2023). Management of Inflammatory Bowel Disease Using E-health Technologies: A Systematic Review and Meta-Analysis. Journal of Crohn's and Colitis, 17(10), 1596-1613. https://doi.org/10.1093/ecco-jcc/jjad075

Vancouver

Kuriakose Kuzhiyanjal AJ, Nigam GB, Antoniou GA, Farraye FA, Cross RK, Limdi JK. Management of Inflammatory Bowel Disease Using E-health Technologies: A Systematic Review and Meta-Analysis. Journal of Crohn's and Colitis. 2023;17(10):1596-1613. doi:10.1093/ecco-jcc/jjad075

BibTeX
@article{KuriakoseKuzhiyanjal2023,
  author = {Kuriakose Kuzhiyanjal, Anish J and Nigam, Gaurav B and Antoniou, George A and Farraye, Francis A and Cross, Raymond K and Limdi, Jimmy K},
  title = {Management of Inflammatory Bowel Disease Using E-health Technologies: A Systematic Review and Meta-Analysis},
  journal = {Journal of Crohn's and Colitis},
  year = {2023},
  volume = {17},
  number = {10},
  pages = {1596--1613},
  doi = {10.1093/ecco-jcc/jjad075}
}
Kostenlos starten →